Trials / Unknown
UnknownNCT02904603
Immune Monitoring of Hepatitis C Under DAA Therapy
Prospective Monitoring of Immune Parameters in Patients With Hepatitis C Under Treatment With Direct Acting Antivirals
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University of Regensburg · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Direct acting antivirals offer a new opportunity to monitor the immune response in Hepatitis C infection. In this study cytokine markers will be measured during therapy up to time point SVR 12 an correlated to clinical Parameters and regular laboratory findings.
Conditions
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2016-11-01
- Completion
- 2017-01-01
- First posted
- 2016-09-19
- Last updated
- 2016-09-21
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02904603. Inclusion in this directory is not an endorsement.